Design Therapeutics, Inc. has been removed from NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.71 USD | -2.88% |
|
-3.64% | +40.00% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.00% | 210M | |
+40.80% | 53.67B | |
+36.70% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Design Therapeutics, Inc.(NasdaqGS: DSGN) dropped from NASDAQ Biotechnology Index